How did OxyContin's marketing and the Purdue Pharma settlements shape the opioid crisis?
A slow-release painkiller launched in 1996 ended in guilty pleas, a Supreme Court ruling and a company ordered to dissolve in 2026.
Guess first
?
Which one is it?
OxyContin is the brand name of , an opioid painkiller made by Purdue Pharma. It was released in 1996, and over the following years it became the centre of a long legal fight. The story matters because it has led to guilty pleas, huge settlements and a company ordered to dissolve.
According to one account of the period, the initial promotion of OxyContin was an organized effort from 1996 to 2001 to dismiss the risk of addiction. Purdue hosted over forty promotional conferences, ran a "Partners Against Pain" campaign and, in that account, trained its sales staff to say the risk of addiction was under one percent. In May 2007 Purdue pleaded guilty to misleading the public about OxyContin's risk of addiction and agreed to pay $600 million.
The legal story was long. Purdue filed for bankruptcy protection on 15 September 2019. In November 2020 the company pleaded guilty to three federal charges relating to its marketing and sales of the drug, and no executives, employees or members of the Sackler family, who owned the firm, were charged in that federal deal. In June 2024, in Harrington v. Purdue Pharma, the Supreme Court, by 5 to 4, overturned a bankruptcy settlement that would have shielded the Sackler family from civil suits, because the Bankruptcy Code does not permit granting liability relief to a party that did not file for bankruptcy. On 28 April 2026 a federal judge formally sentenced the company, in a resolution valued at $8 billion, and ordered it to dissolve and be replaced by a new corporation focused on the public good.
The Sackler family agreed to a multi-billion dollar civil settlement, but has consistently maintained that it did nothing wrong and has never faced criminal prosecution.
Quiz me
0/3
Recap
Purdue pleaded guilty in 2007 and 2020, the Supreme Court rejected the Sackler release in 2024, and sources differ on how much OxyContin explains.
💡 A trick to remember it · Picture a sales pitch that promised "low risk" and a courtroom that spent thirty years reading it back: two guilty pleas, one Supreme Court ruling, one order to dissolve.
Surprising fact · A 5-4 Supreme Court ruling in 2024 overturned a settlement because bankruptcy law does not allow releasing people who did not file for bankruptcy.
Connects to
- 💊 What are opioids, and how do they work in the brain?
- 🌊 What were the three waves of the US opioid crisis?
- 💰 Why do GLP-1 drugs cost so much, and who pays for them?
- ⚗️ Why is fentanyl so potent that tiny amounts can kill?
- 🧪 Why do nine in ten drugs that reach human trials never get approved?
- Drug overdose
- Heroin
Sources (2)
No source, no claim. Every fact in this lesson (14 claims) cites at least one of these.